In a recent business intelligence study, FactMR presents the nitty-gritty of the global prefilled auto injectors market considering 2012-2016 as the historic year and 2017–2022 as the stipulated time frame. The business report highlights the drivers, restraints, opportunities and trends affecting prefilled auto injectors market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
The prefilled auto injectors market study outlines the key regions – Latin America, North America, MEA, Europe and APEJ – along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin.
The prefilled auto injectors market report addresses the below-mentioned queries:
- Why are vendors shifting away from traditional methods of manufacturing prefilled auto injectors?
- How does the global prefilled auto injectors market looks like in the next five years?
- Which end use industry is expected to surpass segment by the end of 2022?
- What innovative products are being introduced by the players in the global prefilled auto injectors market?
- Which regions are showing the fastest market growth?
Forecast Highlights on the Global Market for Prefilled Auto-Injectors
North America is projected to retain its predominant position in the global market for prefilled auto-injectors over 2022. In addition, the region’s prefilled auto-injectors market is anticipated to register an impressive CAGR during the projection period. This growth is mainly attributed to the expanding pool of patients who require drug administration on daily basis in the region. Factors such as low cost of prefilled auto-injectors and quick expansion of the healthcare industry are influencing Asia-Pacific excluding Japan (APEJ)’s prefilled auto injection market. The market in APEJ is expected to surge at little under 16% CAGR between 2017 and 2022. Currently, Europe accounts for over 10% share of the market in terms of revenue and is expected to exhibit lucrative opportunities for market players in the near future.
You can Request an Example Copy from here – https://www.factmr.com/connectus/sample?flag=S&rep_id=169
On the basis of indication, use of prefilled auto-injection is significantly high for treating anaphylaxis indication. Towards the end of the forecast period, nearly US$ 3,200 Mn worth prefilled auto-injectors is estimated to be used for treating anaphylaxis. Online pharmacies are the largest distribution channel for prefilled auto injectors. In terms of revenue, online pharmacies currently account for around 33% share of the market. By the end of 2022, the online pharmacies distribution channel segment is estimated to reach a valuation of nearly US$ 1,500 Mn, reflecting a healthy CAGR.
Ask Industry Professional about Report – https://www.factmr.com/connectus/sample?flag=AE&rep_id=169
Eli Lilly and Company, Becton, Dickinson and Company, Mylan N.V., Amgen Inc., Pfizer Inc., and Antares Pharma, Inc., are the key companies mentioned in the Fact.MR report.
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative